Neeraj Gupta
0000-0002-5500-5218
4 papers found
Refreshing results…
Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies
Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma
Clinical Pharmacology of Ixazomib: The First Oral Proteasome Inhibitor
Missing publications? Search for publications with a matching author name.